Therefore, we aimed this prospective study for evaluating the association between VHL status (mutation, deletion, promoter methylation and pVHL expression), tumour VEGF expression, plasma VEGF levels and usual prognostic parameters in CCRCC. This evidence concerns the gene VEGFA and neoplasm.